Last reviewed · How we verify
Pooled human plasma — Competitive Intelligence Brief
phase 3
Hematology
Small molecule
Live · refreshed every 30 min
Target snapshot
Pooled human plasma (Pooled human plasma) — Turku University Hospital. Pooled human plasma is used as a treatment for various conditions by providing a source of essential proteins and clotting factors.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Pooled human plasma TARGET | Pooled human plasma | Turku University Hospital | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Pooled human plasma CI watch — RSS
- Pooled human plasma CI watch — Atom
- Pooled human plasma CI watch — JSON
- Pooled human plasma alone — RSS
Cite this brief
Drug Landscape (2026). Pooled human plasma — Competitive Intelligence Brief. https://druglandscape.com/ci/pooled-human-plasma. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab